Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up.
Polo Y la Borda J, Castañeda S, Sánchez-Alonso F, Plaza Z, García-Gómez C, Ferraz-Amaro I, Erausquin C, Valls-García R, Fábregas MD, Delgado-Frías E, Mas AJ, González-Juanatey C, Llorca J, González-Gay MA; CARMA Project Collaborative Group.
Polo Y la Borda J, et al. Among authors: llorca j.
Semin Arthritis Rheum. 2024 Mar 27;66:152442. doi: 10.1016/j.semarthrit.2024.152442. Online ahead of print.
Semin Arthritis Rheum. 2024.
PMID: 38555727
Free article.